ResearchMoz

Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media

Publisher Name » GBI Research
Published Date » 2012-07-10
No. Of Pages » 62

GBI Research, the leading business intelligence provider, has released its latest research, Direct to Consumer (DTC) Advertising in Pharmaceuticals Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media, which provides insights into the up-and-coming trends of DTC advertising in the US and of awareness campaigns in Europe. The report provides an in-depth analysis of the types of marketing channels available to pharmaceutical marketers. In particular it focuses on how pharmaceutical marketers can make the most of digital media channels, including online advertising and social media.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

In 2006, over $5 billion was spent on DTC advertising, most of it on the most expensive medium, television. Since then, DTC expenditure has decreased. This is due to a number of reasons, notably the emergence of new media for advertising. Since advertising moved onto the internet, there have been many developments which have revolutionized the way that products are promoted. Pharmaceutical companies were slow to move their advertising online but are now beginning to use it to their advantage. The internet has proven itself to be one of the most cost-effective forms of advertising; full campaigns can be run for the price of one television advertisement.

Social media is another risky yet rewarding method of promotion that pharmaceutical companies are beginning to explore. Through social media, consumers expect to be able to have a public conversation with the representatives of a brand; consumers will always expect their questions to be answered and will not hesitate to discuss adverse effects and any other problems that they consider to be the fault of a brand. However, through social media, pharmaceutical companies have an opportunity to improve their brand image through their responses to these enquires. Another huge advantage of social media is the sharing between friends and peer groups that it enables. A recommendation from a friend is trusted by 90% of people and 70% trust consumer opinions posted online (Google, 2011), so campaigns that are spread between friends by word of mouth can be more effective than traditional methods of widely broadcast DTC.

Scope

  • Data and analysis of traditional media channels and newer channels such as online and mobile platforms.
  • Suggestions of how the ROI (return on investment) of a social media campaign can be measured.
  • How to target a campaign to appropriate audiences by altering the media mix.
  • Examples of successful and violative campaigns.
  • Examples of pioneering use of online media channels.
  • How DTC advertising techniques can be transferred to unbranded campaigns in countries where DTC is not permitted.
Reasons to buy

  • Understand how DTC advertising has changed over the last decade.
  • Develop the use of new media types such as social media and mobile.
  • Create a more tailored advertising campaign designed to reach a targeted audience.
  • Develop key strategic initiatives by understanding the way that patients use different media.
  • Accelerate the delivery of marketing messages through word-of-mouth communication.
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7

2 Direct to Consumer (DTC) Advertising in Pharmaceuticals -Introduction 8

3 Direct to Consumer (DTC) Advertising in Pharmaceuticals Media Types 11

3.1 Traditional Media Types 13
3.1.1 Television 13
3.1.2 Print 17
3.1.3 Other 18
3.2 Online and Social Media 18
3.2.2 Advertisement Placement 20
3.2.3 Twitter 21
3.2.4 Facebook 27
3.2.5 YouTube 27
3.3 Mobile 28
3.3.1 The Importance of a Mobile-enabled Website 28
3.3.2 Applications 28
3.4 Managing Media Types 29
3.4.1 Increasing and Measuring ROI of Social Media 29
3.4.2 Choosing the Correct Media Mix 36

4 DTC Advertising in the US 39
4.1 Introduction 39
4.1.1 History of DTC in the US 39
4.1.2 Impact of DTC in the US 41
4.1.3 Current DTC US Market 42
4.2 FDA Regulations 44
4.2.1 2011 Guidance for Industry the FDAs Response to Social Media Use 44
4.2.2 45-Day Ad Review 45
4.3 Innovative Campaign Examples 46
4.3.1 Lantus (Insulin Glargine) Sanofi US 46
4.3.2 Spiriva Boehringer Ingelheim Pharmaceuticals Inc. 46
4.4 Controversial Campaign Examples 47
4.4.1 Copaxone (Glatiramer Acetate) Teva Pharmaceutical Industries 47
4.4.2 Victoza (Liraglutide [rDNA Origin] Injection) Novo Nordisk A/S 49

5 European Union 51
5.1 Introduction 51
5.2 EU Regulations for DTC Advertising 51
5.2.1 High Level Pharmaceutical Forum A Move to Push Branded DTC Advertising in Europe 52
5.2.2 EC Proposal on Restricted Branded Advertising Possible Entry Point for DTC Advertising Penetration in the Continent 52
5.2.3 Budget Cuts and National Health Services 53
5.2.4 Awareness Campaigns 53
5.3 Conclusion 54

6 Other Markets 55
6.1 New Zealand 55
6.2 Trans-Tasman Initiative 55

7 Conclusion 56

8 Key Takeaway 57

9 Appendix 58

9.1 Market Definitions 58
9.2 Social Media Definitions 58
9.3 Abbreviations 59
9.4 Sources 59
9.5 Research Methodology 60
9.5.1 Coverage 60
9.5.2 Secondary Research 61
9.5.3 Primary Research 61
9.5.4 Competitive Landscape 61
9.5.5 Expert Panel Validation 62
9.6 Contact Us 62
9.7 Disclaimer 62

List of Tables


Table 1: Direct to Consumer Advertising in Pharmaceuticals, Media Type Comparisons 12
Table 2: Differences in the US and Europe Healthcare System in the Context of DTC Advertising 51

List of Figures


Figure 1: Direct to Consumer Advertising in Pharmaceuticals, DTC Spend by Therapeutic Class,%, 2011 9
Figure 2: Direct to Consumer Advertising in Pharmaceuticals, Total Promotional Spending on Prescription Drugs, $bn, 19962011 10
Figure 3: Direct to Consumer Advertising in Pharmaceuticals , DTC Average Budget Allocation, DTC Expenditure on Top Three Media Types, %, 2010 11
Figure 4: Direct to Consumer Advertising in Pharmaceuticals, FDA Guidelines on DTC Marketing of Pharmaceuticals, 2009 14
Figure 5: Direct to Consumer Advertising in Pharmaceuticals, Factors Influencing Decrease in DTC Spending, 20072011 16
Figure 6: Direct to Consumer Advertising in Pharmaceuticals, Proliferation of Brand Message Through Word of Mouth 19
Figure 7: Direct to Consumer Advertising in Pharmaceuticals, Top 10 Most Visited Social Network Sites in the US, 2011 20
Figure 8: Direct to Consumer Advertising in Pharmaceuticals, Twitter Account Information 15 Major Pharmaceutical Users 22
Figure 9: Direct to Consumer Advertising in Pharmaceuticals, Most Commonly Tweeted Topic for Pharmaceutical Accounts 23
Figure 10: Direct to Consumer Advertising in Pharmaceuticals, Tweet Topics AstraZenecas Tweet Chat, 2011 24
Figure 11: Direct to Consumer Advertising in Pharmaceuticals, AstraZeneca, Consumer Sentiment During Twitter Chat, 2011 25
Figure 12: Direct to Consumer Advertising in Pharmaceuticals, Tweet Topics Shires @ADHDSupport 26
Figure 13: Direct to Consumer Advertising in Pharmaceuticals, Types of YouTube Advertisement 28
Figure 14: Direct to Consumer Advertising in Pharmaceuticals, Campaign Reach 31
Figure 15: Direct to Consumer Advertising in Pharmaceuticals, Campaign Engagement 32
Figure 16: Direct to Consumer Advertising in Pharmaceuticals, Campaign Attention 33
Figure 17: Direct to Consumer Advertising in Pharmaceuticals, Campaign Positive Sentiment, % 33
Figure 18: Direct to Consumer Advertising in Pharmaceuticals, Social Media Promotion to Prescription 34
Figure 19: Direct to Consumer Advertising in Pharmaceuticals, Factors for Budget Allocation and Media Mix 36
Figure 20: Direct to Consumer Advertising in Pharmaceuticals, Percentage Change of National Health Expenditure, 19702010 41
Figure 21: Direct to Consumer Advertising in Pharmaceuticals, US DTC Spend by Company, $m, 2011 42
Figure 22: Direct to Consumer Advertising in Pharmaceuticals, Percentage Change in US DTC Spend by Company, 2010 2011 42
Figure 23: Direct to Consumer Advertising in Pharmaceuticals, US DTC Spend by Brand, $m, 2011 43
Figure 24: Direct to Consumer Advertising in Pharmaceuticals, Percentage Change in US DTC Spend by Brand, 20102011 43
Figure 25: Direct to Consumer Advertising in Pharmaceuticals, Team Copaxone Campaign Regulation Breaching Statements 48
Figure 26: Royal Pharmaceutical Society of Great Britain on EU Proposal to Allow Restricted Branded DTC Advertising 53

Upcoming Reports:

Functional Drinks Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The functional drinks market is gaining momentum with improvements in quality and introduction of new products in the market. Introduction of energy drinks and Nutraceutical drinks have added to the growth of this market. Sports drinks with new and innovative flavors are playing a vital role in the steady growth of the functional drinks industry. Increasing consumer awareness towards health concerns is driving the energy drinks segments of this market. Energy drinks supply extra energy in the form of glucose. Nutraceutical drinks are meant for particular class and it is the smallest...
Specialty Surfactants Market And BioSurfactants Market : Global Scenario, Raw Material And Consumption Trends, Industry Analysis, Size, Share & Forecast 2010 - 2018
By - Transparency Market Research
Surfactants are essentially compounds that enhance cleaning efficiency, primarily by emulsifying, wetting, dispersing or modifying lubricity of water-based compositions. Surfactants are manufactured from two basic routes, namely; 1.Oleochemical (natural vegetable oils) 2.Synthetic (petrochemicals) The global surfactants market, which was estimated to be over 15 million tons in 2011, has been undergoing a tumultuous phase with increasing raw material prices, tightening regulatory scenario and increasing calls for sustainability. The market is expected to grow at a...
Welding Products Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012 - 2018
By - Transparency Market Research
Welding is a fabrication process particularly used in metal processing and has a wide range of applications from small to large industries. Compared to all other metal joining methods, this method is found to be the most economical and effective as well. This is the only method that can be used in space and in underwater and air. The global market for welding is expected to grow at a substantial rate through 2018 and is estimated to cross USD 22 billion by 2018. Gas and consumable equipment are together dominating the current welding market and account for more that 60% of the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...